These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26568301)

  • 21. Associations of MDM2 SNP309, transcriptional activity, mRNA expression, and survival in stage I non-small-cell lung cancer patients with wild-type p53 tumors.
    Chien WP; Wong RH; Cheng YW; Chen CY; Lee H
    Ann Surg Oncol; 2010 Apr; 17(4):1194-202. PubMed ID: 19941079
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Bedekovics T; Hussain S; Zhang Y; Ali A; Jeon YJ; Galardy PJ
    Cancer Res; 2021 Mar; 81(5):1321-1331. PubMed ID: 33355202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
    Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
    Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
    Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
    Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDM2 overexpression deregulates the transcriptional control of RB/E2F leading to DNA methyltransferase 3A overexpression in lung cancer.
    Tang YA; Lin RK; Tsai YT; Hsu HS; Yang YC; Chen CY; Wang YC
    Clin Cancer Res; 2012 Aug; 18(16):4325-33. PubMed ID: 22733537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma.
    Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O
    Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A conserved RAD6-MDM2 ubiquitin ligase machinery targets histone chaperone ASF1A in tumorigenesis.
    Wang C; Chang JF; Yan H; Wang DL; Liu Y; Jing Y; Zhang M; Men YL; Lu D; Yang XM; Chen S; Sun FL
    Oncotarget; 2015 Oct; 6(30):29599-613. PubMed ID: 26336826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.
    Peng J; Wang Q; Liu H; Ye M; Wu X; Guo L
    Tumour Biol; 2016 Sep; 37(9):11959-11971. PubMed ID: 27101199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies.
    Peterson LF; Sun H; Liu Y; Potu H; Kandarpa M; Ermann M; Courtney SM; Young M; Showalter HD; Sun D; Jakubowiak A; Malek SN; Talpaz M; Donato NJ
    Blood; 2015 Jun; 125(23):3588-97. PubMed ID: 25814533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression characteristics of the USP24 gene in the mouse testis during spermatogenesis].
    Hu QY; Deng Q; Zhang JW; Zhi F; Sun R; Liang H
    Zhonghua Nan Ke Xue; 2017 Nov; 23(11):963-968. PubMed ID: 29738159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased Δ133p53 mRNA in lung carcinoma corresponds with reduction of p21 expression.
    Fragou A; Tzimagiorgis G; Karageorgopoulos C; Barbetakis N; Lazopoulos A; Papaioannou M; Haitoglou C; Kouidou S
    Mol Med Rep; 2017 Apr; 15(4):1455-1460. PubMed ID: 28260096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mouse double minute 2 (MDM2) upregulates Snail expression and induces epithelial-to-mesenchymal transition in breast cancer cells in vitro and in vivo.
    Lu X; Yan C; Huang Y; Shi D; Fu Z; Qiu J; Yin Y
    Oncotarget; 2016 Jun; 7(24):37177-37191. PubMed ID: 27184007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MDMX is a prognostic factor for non-small cell lung cancer and regulates its sensitivity to cisplatin.
    Zhao H; Xie YZ; Xing R; Sun M; Chi F; Zeng YC
    Cell Oncol (Dordr); 2017 Aug; 40(4):357-365. PubMed ID: 28567715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA16 is a potential biomarker for diagnosis of early-stage lung cancer that promotes cell proliferation by regulating the cell cycle.
    Zhu H; Zhang L; Yan S; Li W; Cui J; Zhu M; Xia N; Yang Y; Yuan J; Chen X; Luo J; Chen R; Xing R; Lu Y; Wu N
    Oncotarget; 2017 Jan; 8(5):7867-7877. PubMed ID: 27999202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. USP33, a new player in lung cancer, mediates Slit-Robo signaling.
    Wen P; Kong R; Liu J; Zhu L; Chen X; Li X; Nie Y; Wu K; Wu JY
    Protein Cell; 2014 Sep; 5(9):704-13. PubMed ID: 24981056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The HAUSP gene plays an important role in non-small cell lung carcinogenesis through p53-dependent pathways.
    Masuya D; Huang C; Liu D; Nakashima T; Yokomise H; Ueno M; Nakashima N; Sumitomo S
    J Pathol; 2006 Apr; 208(5):724-32. PubMed ID: 16450335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. USP7 overexpression predicts a poor prognosis in lung squamous cell carcinoma and large cell carcinoma.
    Zhao GY; Lin ZW; Lu CL; Gu J; Yuan YF; Xu FK; Liu RH; Ge D; Ding JY
    Tumour Biol; 2015 Mar; 36(3):1721-9. PubMed ID: 25519684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of MDM2 polymorphism: increased risk of developing colorectal cancer and a poor prognosis in the Tunisian population.
    Chaar I; Arfaoui TA; El Amine el HO; Mahmoud LB; Khiari M; Sammoud S; Lounis A; Amara S; Gharbi L; Hmida AB; Mzabi S; Bouraoui S
    Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):320-7. PubMed ID: 22266832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer.
    Fujikane T; Nishikawa N; Toyota M; Suzuki H; Nojima M; Maruyama R; Ashida M; Ohe-Toyota M; Kai M; Nishidate T; Sasaki Y; Ohmura T; Hirata K; Tokino T
    Breast Cancer Res Treat; 2010 Aug; 122(3):699-710. PubMed ID: 19859801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. USP24 promotes drug resistance during cancer therapy.
    Wang SA; Young MJ; Wang YC; Chen SH; Liu CY; Lo YA; Jen HH; Hsu KC; Hung JJ
    Cell Death Differ; 2021 Sep; 28(9):2690-2707. PubMed ID: 33846536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.